磷酸利美尼定 T6641

Product Introduction
Bioactivity


英文名: Rilmenidine Phosphate

描述: Rilmenidine phosphate 是一种新型的抗高血压药物和口服活性选择性 I1 咪唑啉受体激动剂。它可调节白血病细胞增殖，刺激促凋亡蛋白 Bax，从而诱导人白血病 K562 细胞线粒体通路的紊乱和凋亡。它可通过减少交感神经过度活跃而发挥中枢作用，并通过抑制 Na+/H+反向转运而在肾脏中发挥作用。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 4 mg/mL (14.38 mM)


关键字: cells | inhibit | Imidazoline Receptor | Beta Receptor | K562 | proliferation | mitochondrial | Adrenergic Receptor | Rilmenidine | antihypertensive | leukemic | proapoptotic | Rilmenidine Phosphate | Autophagy | Inhibitor | Apoptosis

相关产品: Eragidomide | Rigosertib | Phytohemagglutinin | Torkinib | Voreloxin | Suramin Sodium Salt | Oleic acid | FB23-2 | LAT1-IN-1 | RIPGBM

相关库: Anti-Aging Compound Library | Drug Repurposing Compound Library | Anti-Neurodegenerative Disease Compound Library | Approved Drug Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | GPCR Compound Library | Anti-Cancer Approved Drug Library | EMA Approved Drug Library | Anti-Alzheimer's Disease Compound Library

磷酸利美尼定 T6641信息由TargetMol中国为您提供，如您想了解更多关于磷酸利美尼定 T6641报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途